The legal complaint, filed by Wolf Haldenstein Adler Freeman & Herz LLP, accuses The Ensign Group and certain executives of defrauding Medicaid and Medicare while falsifying internal records to obscure patient care failures. The allegations center on claims that the company utilized self-reporting measures to mask the widespread neglect of individuals requiring high levels of medical attention.
In section Releases
Class Action Lawsuit Targets The Ensign Group Over Care Allegations
Investors who purchased The Ensign Group shares between February 10, 2022, and June 18, 2026, face a December 7, 2026, deadline to join a newly filed class action lawsuit. The litigation follows allegations that the company maintained a business model built on the systematic neglect of elderly residents and insurance fraud.
Scrutiny intensified on June 8, 2026, following a report from Hunterbrook Media titled "Ensign: The Nursing Home Empire Built on Fatal Neglect." The investigation, which spanned five months, detailed accounts from former employees across multiple states regarding systematic misrepresentations of care quality. Following the report, Ensign stock dropped $13.88 per share, closing at $156.42. Affected shareholders are encouraged to contact Gregory Stone at the firm to discuss potential participation in the case.
Comments (0)
No comments yet. Be the first!